Effect of metalloproteinase inhibitor on corneal cytokine expression after alkali injury

Investigative Ophthalmology and Visual Science

Volumn 40, Issue 10, 1999, Pages 2430-2434

  Sotozono, Chie ^a   He, Jiucheng ^a   Tei, Mamoru ^a   Honma, Yoich ^a   Kinoshita, Shigeru ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALI; CYTOKINE; ILOMASTAT; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; MATRIX METALLOPROTEINASE INHIBITOR; SODIUM HYDROXIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CATARACT; CAUSTIC BURN; CONTROLLED STUDY; CORNEA EPITHELIUM; CORNEA INJURY; CORNEA OPACITY; CYTOKINE PRODUCTION; DRUG EFFECT; FEMALE; HYPHEMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; TISSUE REGENERATION; TOPICAL DRUG ADMINISTRATION;

EID: 0032842792     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Itoi M, Gnädinger MC, Slansky HH, Freeman MI, Dohlman CH. Collagenase in the cornea. Exp Eye Res. 1969;8:369-373.
2. Gordon JM, Bauer EA, Eisen AZ. Collagenase in human cornea: immunologic localization. Arch Ophthalmol. 1980;98:341-345.
3. Fini ME, Girard MT. Expression of collagenolytic/gelatinolytic metalloproteinases by normal cornea. Invest Ophthalmol Vis Sci. 1990;31:1779-1788.
4. Matsubara M, Girard MT, Kublin CL, Cintron C, Fini ME. Differential roles for two gelatinolytic enzymes of the matrix metalloproteinase family in the remodeling cornea. Dev Biol. 1991;147:425-439.
5. Brown D, Chwa M, Escobar M, Kenney MC. Characterization of the major matrix degrading metalloproteinase of human corneal stroma. Evidence for an enzyme/inhibitor complex. Exp Eye Res. 1991;52:5-16.
6. Gnädinger MC, Itoi M, Slansky HH, Dohlman CH. The role of collagenase in the alkali-burned cornea. Am J Ophthalmol. 1969; 68:478-483.
7. Brown SI, Weller CA, Wassermann HE. Collagenolytic activity of alkali-burned corneas. Arch Ophthalmol. 1969;81:370-373.
8. Brown SI, Weller CA, Akiya S. Pathogenesis of ulcers of the alkali-burned cornea. Arch Ophthalmol. 1970;83:205-208.
9. Burns FR, Stack MS, Gray RD, Paterson CA. Inhibition of purified collagenase from alkali-burned rabbit corneas. Invest Ophthalmol Vis Sci. 1989;30:1569-1575.
10. Burns FR, Gray RD, Paterson CA. Inhibition of alkali-induced corneal ulceration and perforation by a thiol peptide. Invest Ophthalmol Vis Sci. 1990;31:107-114.
11. Paterson CA, Wells JG, Koklitis PA, Higgs GA, Docherty AJ. Recombinant tissue inhibitor of metalloproteinases type 1 suppresses alkali-burn-induced corneal ulceration in rabbits. Invest Ophthalmol Vis Sci. 1994;35:677-684.
12. Schultz GS, Strelow S, Stern GA, et al. Treatment of alkali-injured rabbit corneas with a synthetic inhibitor of matrix metalloproteinases. Invest Ophthalmol Vis Sci. 1992;33:3325-3331.
13. Wentworth JS, Paterson CA, Gray RD. Effect of a metalloproteinase inhibitor on established corneal ulcers after an alkali burn. Invest Ophthalmol Vis Sci. 1992;33:2174-2179.
14. Sotozono C, He J, Matsumoto Y, et al. Cytokine expression in the alkali-burned cornea. Curr Eye Res. 1997;16:670-676.
15. Sotozono C, Kinoshita S. Growth factors and cytokines in corneal wound healing. In: Nishida T, ed. Corneal Healing Responses to Injuries and Refractive Surgeries. The Hague: Kugler Publications; 1998:29-40.
16. Barletta JP, Angella G, Balch KC, et al. Inhibition of pseudomonal ulceration in rabbit corneas by a synthetic matrix metalloproteinase inhibitor. Invest Ophthalmol Vis Sci. 1996;37:20-28.
17. Sano Y, Osawa H, Sotozono C, Kinoshita S. Cytokine expression during orthotopic corneal allograft rejection in mice. Invest Ophtbalmol Vis Sci. 1998;39:1953-1957.
18. Girard MT, Matsubara M, Fini ME. Transforming growth factor-beta and interleukin-1 modulate metalloproteinase expression by corneal stromal cells. Invest Ophthalmol Vis Sci. 1991;32:2441-2454.
19. Cubitt CL, Tang Q, Monteiro CA, Lausch RN, Oakes JE. IL-8 gene expression in cultures of human corneal epithelial cells and keratocytes. Invest Ophthalmol Vis Sci. 1993;34:3199-3206.
20. Cubitt CL, Lausch RN, Oakes JE. Differences in interleukin-6 gene expression between cultured human corneal epithelial cells and keratocytes. Invest Ophthalmol Vis Sci. 1995;36:330-336.
21. Sakamoto S, Inada K, Chiba K, Yoshida M, Tazawa Y. Production of IL-6 and IL-I α by human corneal epithelial cells. Nippon Ganka Gakkai Zasshi. 1991;95:728-732.
22. West-Mays JA, Sadow PM, Tobin TW, et al. Repair phenotype in corneal fibroblasts is controlled by an interleukin-1 α autocrine feedback loop. Invest Ophthalmol Vis Sci. 1997;38:1367-1379.
23. Pfister RR, Haddox JL, Sommers CI. Effect of synthetic metalloproteinase inhibitor or citrate on neutrophil chemotaxis and the respiratory burst. Invest Ophthalmol Vis Sci. 1997;38:1340-1349.
24. Saika S, Kawashima Y, Okada Y, et al. Recombinant TIMP-1 and -2 enhance the proliferation of rabbit corneal epithelial cells in vitro and the spreading of rabbit corneal epithelium in situ. Curr Eye Res. 1998;17:47-52.
25. Weinreb RN, Kashiwagi K, Kashiwagi F, Tsukahara S, Lindsey JD. Prostaglandins increase matrix metalloproteinase release from human ciliary smooth muscle cells. Invest Ophthalmol Vis Sci. 1997; 38:2772-2780.
26. Alexander JP, Samples JR, Van BE, Acott TS. Expression of matrix metalloproteinases and inhibitor by human trabecular meshwork. Invest Ophthalmol Vis Sci. 1991;32:172-180.
27. Gearing AJ, Beckett P, Christodoulou M, et al. Processing of tumour necrosis factor-α precursor by metalloproteinases. Nature. 1994;370:555-557.
28. McGeehan GM, Becherer JD, Bast RJ, et al. Regulation of tumour necrosis factor-α processing by a metalloproteinase inhibitor. Nature. 1994;370:558-561.
29. Solorzano CC, Ksontini R, Pruitt JH, et al. A matrix metalloproteinase inhibitor prevents processing of tumor necrosis factor α (TNF α) and abrogates endotoxin-induced lethality. Shock. 1997;7:427-431.
30. Tanaka M, Suda T, Haze K, et al. Fas ligand in human serum. Nat Med. 1996;2:317-322.